Publications & Research
Molnupiravir for treating COVID‐19
To assess the effects of molnupiravir in people with confirmed SARS‐CoV‐2 infection and mild‐to‐moderate symptoms, with or without risk factors for severe disease.
Click here to send us a message.
t: +27 (0)21 938 9962
e: This email address is being protected from spambots. You need JavaScript enabled to view it.
a: Teaching Building, Francie van Zijl Drive
Twitter: @MikeMcCaul3 | @cebhc | @SUBiostatsUnit
Senior Lecturer in Epidemiology and Biostatistics, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa. I have expertise in:
Clinical Epidemiology | Biostatistics | Evidence Synthesis | Guideline Development | Research Methods | Postgraduate Teaching and Learning | Prehospital Care | Student Supervision